Commission Implementing Regulation (EU) 2018/1796 of 20 November 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorpyrifos, chlorpyrifos-methyl, clofentezine, dicamba, difenoconazole, diflubenzuron, diflufenican, dimoxystrobin, fenoxaprop-p, fenpropidin, lenacil, mancozeb, mecoprop-p, metiram, nicosulfuron, oxamyl, picloram, pyraclostrobin, pyriproxyfen and tritosulfuron (Text with EEA relevance.)

• CELEX: Implementing Regulation (EU) 2018/1796
• Articles: 3

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by ‘31 January 2020’;

(2)

in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by ‘31 January 2020’;

(3)

in the sixth column, expiration of approval, of row 111, Chlorpyrifos, the date is replaced by ‘31 January 2020’;

(4)

in the sixth column, expiration of approval, of row 112, Chlorpyrifos-methyl, the date is replaced by ‘31 January 2020’;

(5)

in the sixth column, expiration of approval, of row 114, Mancozeb, the date is replaced by ‘31 January 2020’;

(6)

in the sixth column, expiration of approval, of row 115, Metiram, the date is replaced by ‘31 January 2020’;

(7)

in the sixth column, expiration of approval, of row 116, Oxamyl, the date is replaced by ‘31 January 2020’;

(8)

in the sixth column, expiration of approval, of row 128, Dimoxystrobin, the date is replaced by ‘31 January 2020’;

(9)

in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 December 2019’;

(10)

in the sixth column, expiration of approval, of row 170, Nicosulfuron, the date is replaced by ‘31 December 2019’;

(11)

in the sixth column, expiration of approval, of row 171, Clofentezine, the date is replaced by ‘31 December 2019’;

(12)

in the sixth column, expiration of approval, of row 172, Dicamba, the date is replaced by ‘31 December 2019’;

(13)

in the sixth column, expiration of approval, of row 173, Difenoconazole, the date is replaced by ‘31 December 2019’;

(14)

in the sixth column, expiration of approval, of row 174, Diflubenzuron, the date is replaced by ‘31 December 2019’;

(15)

in the sixth column, expiration of approval, of row 176, Lenacil, the date is replaced by ‘31 December 2019’;

(16)

in the sixth column, expiration of approval, of row 178, Picloram, the date is replaced by ‘31 December 2019’;

(17)

in the sixth column, expiration of approval, of row 179, Pyriproxyfen, the date is replaced by ‘31 December 2019’;

(18)

in the sixth column, expiration of approval, of row 180, Bifenox, the date is replaced by ‘31 December 2019’;

(19)

in the sixth column, expiration of approval, of row 181, Diflufenican, the date is replaced by ‘31 December 2019’;

(20)

in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 December 2019’;

(21)

in the sixth column, expiration of approval, of row 183, Fenpropidin, the date is replaced by ‘31 December 2019’;

(22)

in the sixth column, expiration of approval, of row 186, Tritosulfuron, the date is replaced by ‘30 November 2019’.